Severity
Moderate
FDA Drug recall · Reported July 2, 2025
Lack of assurance of sterility: pinholes, within the finger boxes used during Form Fill Seal process resulting in leaks.
B Braun Medical INC recalled 0.9% Sodium Chloride Injection USP, 500 mL, packaged in 500 mL excel containers and furth… - a moderate-severity action.
0.9% Sodium Chloride Injection USP, 500 mL, packaged in 500 mL excel containers and furth… was recalled by B Braun Medical INC in July 2, 2025. Reason: Lack of assurance of sterility: pinholes, within the finger boxes used during Form Fill Seal process resultin…. Check the official notice for the remedy. Verify recall #D-0491-2025 with the FDA Drug before acting.
The recall
B Braun Medical INC issued this moderate-severity FDA Drug recall-Lack of assurance of sterility: pinholes, within the finger boxes used during Form Fill Seal process resultin….
Sourced from official FDA Drug enforcement records. Verify recall #D-0491-2025 with the agency before acting. Full product description, hazard, remedy, and related recalls are below.
This FDA Drug action (record #D-0491-2025) was formally reported on July 2, 2025, with the manufacturer initiating the action on June 16, 2025. It is classified under Moderate severity (Class II), with a current status of Ongoing. B Braun Medical INC is listed as the recalling firm, operating out of Allentown, PA. Federal records list the affected scope as 187,656 containers.
The documented reason for this recall is: Lack of assurance of sterility: pinholes, within the finger boxes used during Form Fill Seal process resulting in leaks. Distribution data in the federal record shows the product reached: USA Nationwide. Distribution scope directly affects the consumer exposure window and determines whether a recall remains regional or escalates into a nationwide advisory.
Within the same product category the archive holds 6 closely related recalls, 5 from FDA Drug - clustering in a narrow category often points to a systemic quality-control or supplier issue rather than a one-off defect. Always verify the recall number against the official agency record before acting.
Where this recall sits in its category - 14,287 drugs & medications recalls on record
Of 101,704 recalls in the database, 24,878 are high severity, 72,426 moderate, and 4,400 low. This recall is classified moderate severity.
Counts reflect market size and reporting activity, not inherent danger, we do not rank products by risk from raw recall volume.
Severity
Moderate
Affected scope
187,656 containers
Related Recalls
6
5 from same agency
0.9% Sodium Chloride Injection USP, 500 mL, packaged in 500 mL excel containers and further packaged 24 per case, Rx only, B.Braun Medical Inc., Bethlehem, PA 18018-3524, USA, NDC 0264-7800-10.
Lack of assurance of sterility: pinholes, within the finger boxes used during Form Fill Seal process resulting in leaks.
| Attribute | Value |
|---|---|
| Agency | U.S. Food and Drug Administration |
| Severity class | Moderate (Class II) |
| Status | Ongoing |
| Recall number | D-0491-2025 |
| Date reported | July 2, 2025 |
| Date initiated | June 16, 2025 |
| Recalling firm | B Braun Medical INC |
| Firm location | Allentown, PA |
| Affected scope | 187,656 containers |
| Distribution | USA Nationwide |
Profile values are sourced directly from the official FDA Drug enforcement record. Source: U.S. Food and Drug Administration.
What to do with this recall
Match your product against the recall record, then act on the agency remedy.
This page summarizes the official FDA Drug record for research and awareness; it is not legal, medical, or safety advice. Verify with the issuing agency before acting.
Other recalls in the same product category, useful for spotting patterns across the same defect class or manufacturer.
AbbVie Inc. · 2026-06-03
Llorens Pharmaceuticals International Division, Inc. · 2026-05-27
Safecor Health, LLC · 2026-05-27
IntegraDose Compounding Services LLC · 2026-05-27
Lupin Pharmaceuticals Inc. · 2026-05-27
Compare this recall with PRED MILD, prednisolone acetate ophthalmic suspension, USP,… →
Every figure on PlainRecalls is rendered directly from official FDA, CPSC and NHTSA recall records, no number is typed in by an editor. This recall: FDA Drug, reported July 2, 2025. Severity classes follow each agency's own taxonomy (FDA Class I/II/III; CPSC and NHTSA by hazard type), and related-recall context is computed across the full archive. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of July 2026.